Phosphatidylinositol 3-Kinase Signaling Does Not Activate the Wnt Cascade

Mutational activation of the phosphatidylinositol 3-kinase (PI3K) pathway occurs in a wide variety of tumors, whereas activating Wnt pathway mutants are predominantly found in colon cancer. Because GSK3 is a key component of both pathways, it is widely assumed that active PI3K signaling feeds positively into the Wnt pathway by protein kinase B (PKB)-mediatefd inhibition of GSK3. In addition, PKB has been proposed to modulate the canonical Wnt signaling through direct stabilization and nuclear localization of β-catenin. Here, we show that compartmentalization by Axin of GSK3 prohibits cross-talk between the PI3K and Wnt pathways and that Wnt-mediated transcriptional activity is not modulated by activation of the PI3K/PKB pathway.

[1]  C. Kenyon,et al.  Activation of a C. elegans Antennapedia homologue in migrating cells controls their direction of migration , 1992, Nature.

[2]  P. Cohen,et al.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.

[3]  P. Cohen,et al.  The α‐isoform of glycogen synthase kinase‐3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase‐activated protein kinase‐1 in vitro , 1994, FEBS letters.

[4]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[5]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[6]  L. Honigberg,et al.  Neuronal cell migration in C. elegans: regulation of Hox gene expression and cell position. , 1996, Development.

[7]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[8]  J. Trapman,et al.  Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. , 1998, Cancer research.

[9]  G. Ruvkun,et al.  The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. , 1998, Molecular cell.

[10]  Paul Polakis,et al.  Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β , 1998, Current Biology.

[11]  J. Whangbo,et al.  A Wnt signaling pathway controls hox gene expression and neuroblast migration in C. elegans. , 1999, Development.

[12]  F. McCormick,et al.  Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.

[13]  S. Dedhar,et al.  Tumor Suppressor Pten Inhibits Nuclear Accumulation of β-Catenin and T Cell/Lymphoid Enhancer Factor 1–Mediated Transcriptional Activation , 2001, The Journal of cell biology.

[14]  H Clevers,et al.  Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. , 2001, Cancer research.

[15]  Philip Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001 .

[16]  Hendrik C Korswagen,et al.  The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans. , 2002, Genes & development.

[17]  Hendrik C Korswagen,et al.  Canonical and non-canonical Wnt signaling pathways in Caenorhabditis elegans: variations on a common signaling theme. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  Reinhart Heinrich,et al.  The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway , 2003, PLoS biology.

[19]  J. Whangbo,et al.  Identification of genes that regulate a left-right asymmetric neuronal migration in Caenorhabditis elegans. , 2003, Genetics.

[20]  D. Alessi,et al.  Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis , 2005, The EMBO journal.

[21]  Tak W. Mak,et al.  Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.

[22]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[23]  B. Doble,et al.  Glycogen synthase kinase-3--an overview of an over-achieving protein kinase. , 2006, Current drug targets.

[24]  Kathleen R. Cho,et al.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. , 2007, Cancer cell.

[25]  Mieke Schutte,et al.  Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines , 2007, Molecular Cancer Research.

[26]  H. Korswagen,et al.  Migration of neuronal cells along the anterior-posterior body axis of C. elegans: Wnts are in control. , 2007, Current opinion in genetics & development.